CELLECTAR BIOSCIENCES INC (CLRB) Stock Analyst Ratings
NASDAQ:CLRB - Nasdaq - US15117F8077 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to CLRB. The Buy consensus is the weighted average rating of the current analysts ratings.
CLRB was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about CLRB.
In the previous month the buy percentage consensus was at a similar level.
CLRB was analyzed by 10 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-14 | Maxim Group | Downgrade | Buy -> Hold |
| 2024-12-11 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2024-11-19 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-11 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-28 | Roth MKM | Maintains | Buy -> Buy |
| 2024-03-28 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-04 | Roth MKM | Reiterate | Buy -> Buy |
| 2022-11-04 | HC Wainwright & Co. | Maintains | Buy |